Predicting risk of COPD in primary care: Development and validation of a clinical risk score

BMJ Open Respiratory Research

Volumn 2, Issue 1, 2015, Pages 1-10

  Haroon, Shamil ^a   Adab, Peymane ^a   Riley, Richard D ^a   Marshall, Tom ^a   Lancashire, Robert ^a   Jordan, Rachel E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ACCURACY; ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; BODY MASS; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COPD RISK SCORE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDATION PROCESS;

EID: 84989789421     PISSN: None     EISSN: 20524439     Source Type: Journal    
DOI: 10.1136/bmjresp-2014-000060     Document Type: Article

References (24)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
2. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007;370:741-50.
3. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366:1875-81.
4. Jones RC, Price D, Ryan D, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014;2:267-6.
5. An outcomes strategy for people with chronic obstructive pulmonary disease (COPD) and asthma in England. London: Department of Health, 2011.
6. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, managment, and prevention of chronic obstructive pulmonary disease global initiative for chronic obstructive lung disease, 2013.
7. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006;73:285-95.
8. Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6(R) in primary care. Prim Care Respir J 2011;20:190-8, 2 p following 98.
9. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008;63:402-7.
10. Mapel DW, Frost J, Hurley JS, et al. An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm 2006;12:458-65.
11. Mapel DW, Petersen H, Roberts MH, et al. Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care 2010;16:505-12.
12. Smidth M, Sokolowski I, Kaersvang L, et al. Developing an algorithm to identify people with Chronic Obstructive Pulmonary Disease (COPD) using administrative data. Bmc Med Inform Decis 2012;12:38.
13. Kotz D, Simpson CR, Viechtbauer W, et al. Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD. NPJ Prim Care Respir Med 2014;24:14011.
14. Clinical Practice Research Database. London: The Medicines and Healthcare products Regulatory Agency, 2013.
15. Read Codes. London: NHS Connecting for Health, 2013.
16. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011;342:d549.
17. Jordan RE, Lam KB, Cheng KK, et al. Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach. Thorax 2010;65:492-8.
18. Mapel DW, Frost FJ, Hurley JS, et al. An algorithm for the identification of undiagnosed COPD cases using administrative claims data. 2006;12:458-65.
19. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009;374:721-32.
20. Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116:416-23.
21. Quint JK, Mullerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open 2014;4:e005540.
22. Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006;130:1129-37.
23. Ganna A, Reilly M, de Faire U, et al. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol 2012;175:715-24.
24. Janes H, Pepe MS. Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value. Biometrics 2008;64:1-9.